首页|期刊导航|检验医学与临床|加味健肾方联合他克莫司治疗特发性膜性肾病的临床疗效及对肾功能、抗PLA2R抗体水平的影响

加味健肾方联合他克莫司治疗特发性膜性肾病的临床疗效及对肾功能、抗PLA2R抗体水平的影响OA

Clinical efficacy of modified Jiawei Jianshen decoction combined with tacrolimus in the treatment of idiopathic membranous nephropathy and its influence on BUN,SCr levels and PLA2R titer

中文摘要英文摘要

目的 探讨加味健肾方联合他克莫司治疗特发性膜性肾病(IMN)的临床疗效及对肾功能、抗磷脂酶A2受体(PLA2R)抗体水平的影响.方法 选取2022年1月至2024年12月北京市昌平区中医医院收治的106例IMN患者作为研究对象,采用随机数字表法分为对照组和观察组,每组53例.对照组在基础治疗的同时给予他克莫司治疗,观察组在对照组的基础上联合加味健肾方治疗.治疗3个月后评价疗效,其中西医疗效依据临床症状、体征及24 h尿蛋白定量(24 h UP)、血清清蛋白(ALB)水平评估,中医疗效依据中医证候积分评估.同时比较2组治疗前、治疗3个月后肾功能[血尿素氮(BUN)、血清肌酐(SCr)水平]、脂代谢[甘油三酯(TG)、总胆固醇(TC)]、蛋白尿[24 hUP、尿清蛋白肌酐比值(UACR)]、ALB、抗PLA2R抗体水平,并记录不良反应.结果 2组治疗3个月后 UACR及BUN、SCr、24 hUp、TG、TC、抗PLA2R抗体水平均低于治疗前,ALB水平均高于治疗前,倦怠乏力、水肿、畏寒肢冷、腰膝酸软、脘腹胀满积分及总分均低于治疗前,且观察组治疗3个月后 UACR及BUN、SCr、24 hUp、TG、TC、抗PLA2R抗体水平均低于对照组,ALB水平高于对照组,倦怠乏力、水肿、畏寒肢冷、腰膝酸软积分及总分均低于对照组,差异均有统计学意义(P<0.05).2组治疗3个月后脘腹胀满积分比较,差异无统计学意义(P>0.05).观察组西医总有效率为92.45%,高于对照组的77.36%,差异有统计学意义(P<0.05);观察组中医证候总有效率为88.68%,高于对照组的67.92%,差异有统计学意义(P<0.05).2组不良反应总发生率比较,差异无统计学意义(P>0.05).结论 加味健肾方联合他克莫司治疗IMN疗效明显,可改善患者的临床症状及BUN、SCr、抗PLA2R抗体等指标.

Objective To investigate the clinical efficacy of Jiawei Jianshen decoction combined with ta-crolimus in the treatment of idiopathic membranous nephropathy(IMN)and its effect on renal function and anti-phospholipase A2 receptor(PLA2R)antibody level.Methods A total of 106 patients with IMN admitted to Beijing Changping District Hospital of Traditional Chinese Medicine from January 2022 to December 2024 were selected as the research objects,and they were divided into control group and observation group by ran-dom number table method,with 53 cases in each group.The control group was treated with tacrolimus in addi-tion to basic treatment,and the observation group was treated with Jiawei Jianshen decoction on the basis of the control group.After 3 months of treatment,the curative effect was evaluated.The curative effect of west-ern medicine was evaluated according to clinical symptoms,signs,24 h urinary protein quantification(24 hUP)and serum albumin(ALB)level,and the curative effect of TCM was evaluated according to TCM syndrome score.At the same time,the levels of renal function[blood urea nitrogen(BUN),serum creatinine(SCr)levels],lipid metabolism[triglyceride(TG),total cholesterol(TC)],proteinuria[24 hUP,urinary al-bumin creatinine ratio(UACR)],ALB,anti-PLA2R antibody were compared between the two groups before treatment and 3 months after treatment,and adverse reactions were recorded.Results After 3 months of treatment,the levels of UACR,BUN,SCr,24 hUp,TG,TC,and anti-PLA2R antibody in the two groups were lower than those before treatment,the level of ALB was higher than that before treatment,and the scores of fatigue,edema,cold limbs,waist and knee soreness,abdominal distention and total score were lower than those before treatment,after 3 months of treatment,the levels of UACR,BUN,SCr,24 hUp,TG,TC and anti-PLA2R antibody in the observation group were lower than those in the control group,the level of ALB was higher than that in the control group,and the scores of fatigue,edema,cold limbs,waist and knee soreness and total score in the observation group were lower than those in the control group,and the differences were sta-tistically significant(P<0.05).There was no statistically significant difference in abdominal distension score between the two groups after 3 months of treatment(P>0.05).The total effective rate of western medicine in the observation group was 92.45%,which was higher than 77.36%in the control group,and the difference was statistically significant(P<0.05).The total effective rate of TCM syndromes in the observation group was 88.68%,which was higher than 67.92%in the control group,and the difference was statistically signifi-cant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Jiawei Jianshen decoction combined with tacrolimus is effective in the treatment of IMN,which can improve the clinical symptoms,BUN,SCr,anti-PLA2R antibody and other indi-cators.

林珊珊;郞睿;陈烨;李文超;李雪;吴蕾;张元明

北京市昌平区中医医院肾病科,北京 102200中国中医科学院西苑医院肾病科,北京 100091北京市昌平区中医医院肾病科,北京 102200北京市昌平区中医医院肾病科,北京 102200北京市昌平区中医医院肾病科,北京 102200北京市昌平区中医医院肾病科,北京 102200北京市昌平区中医医院脑病科,北京 102200

医药卫生

加味健肾方他克莫司特发性膜性肾病尿素氮血肌酐磷脂酶A2受体

Jiawei Jianshen decoctiontacrolimusidiopathic membranous nephropathyurea nitro-genserum creatininephospholipase A2 receptor

《检验医学与临床》 2026 (7)

886-891,897,7

国家自然科学基金项目(82274503).

10.3969/j.issn.1672-9455.2026.07.004

评论